749476
Last Update Posted: 2011-06-08
Recruiting has ended
Males accepted | 12 Years + |
1 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX
The purpose of this study is to collect data around the period of the conversion from plasma-derived Factor IX (pdFIX) to BeneFIX. The main information collected will be: a retrospective history of the bleedings in the 3-month period before the conversion, the recovery with pdFIX just before the conversion and with BeneFIX just after the conversion, and a prospective history of the bleedings in the 3 month period following the conversion.
The switch to BeneFIX has already been decided by the investigator. Patients will be followed up to 3 months after the switch.
Eligibility
Relevant conditions:
Hemophilia B
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov